ArticleFrontiers in artificial intelligence2024
Advanced interpretable diagnosis of Alzheimer's disease using SECNN-RF framework with explainable AI.
Article in Frontiers in artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- MidFusionEfficientV2: Improving Ophthalmic Diagnosis with Mid-Level RGB-LBP Fusion and SE Attention.Journal of clinical medicine · 2026Article
- Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review.BMC medical informatics and decision making · 2026Article
- PredatorNet: a clinically trustworthy deep learning framework for multi-class Alzheimer's disease classification using MRI.Frontiers in aging neuroscience · 2026Article
- Article
- FuzzyFed-CNN: secure and explainable multimodal federated learning for early Alzheimer's diagnosis.Frontiers in artificial intelligence · 2026Article
- Artificial neural networks fighting real neural decline: a systematic review of AI in Alzheimer's research.Artificial intelligence review · 2026Article
- Leveraging explainable artificial intelligence with ensemble of deep learning model for dementia prediction to enhance clinical decision support systems.Scientific reports · 2025Article
- Explainable Artificial Intelligence in Neuroimaging of Alzheimer's Disease.Diagnostics (Basel, Switzerland) · 2025Review
- Artificial intelligence in neurodegenerative diseases research: a bibliometric analysis since 2000.Frontiers in neurology · 2025Review
- Advancing Alzheimer's Diagnosis with AI-Enhanced MRI: A Review of Challenges and Implications.Current neuropharmacology · 2025Review
- Advanced interpretable diagnosis of Alzheimer's disease using SECNN-RF framework with explainable AI.Frontiers in artificial intelligence · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of Alzheimer's disease (AD) is vital for effective treatment, as interventions are most successful in the disease's early stages. Combining Magnetic Resonance Imaging (MRI) with artificial intelligence (AI) offers significant potential for enhancing AD diagnosis. However, traditional AI models often lack transparency in their decision-making processes. Explainable Artificial Intelligence (XAI) is an evolving field that aims to make AI decisions understandable to humans, providing transparency and insight into AI systems. This research introduces the Squeeze-and-Excitation Convolutional Neural Network with Random Forest (SECNN-RF) framework for early AD detection using MRI scans. The SECNN-RF integrates Squeeze-and-Excitation (SE) blocks into a Convolutional Neural Network (CNN) to focus on crucial features and uses Dropout layers to prevent overfitting. It then employs a Random Forest classifier to accurately categorize the extracted features. The SECNN-RF demonstrates high accuracy (99.89%) and offers an explainable analysis, enhancing the model's interpretability. Further exploration of the SECNN framework involved substituting the Random Forest classifier with other machine learning algorithms like Decision Tree, XGBoost, Support Vector Machine, and Gradient Boosting. While all these classifiers improved model performance, Random Forest achieved the highest accuracy, followed closely by XGBoost, Gradient Boosting, Support Vector Machine, and Decision Tree which achieved lower accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.